BRCA1 and hepatocellular carcinoma: Comparing to BRCA1 mutant HCC-1937 cells, though cisplatin treatment induced less RAD51 foci formation and γH2AX increase, the RAD51 foci formation can also be inhibited upon RAD51 inhibitor treatment (Figure S1).